• The Changing Nature of the Opioid Crisis
    Oct 1 2025

    The opioid epidemic has killed roughly 900,000 Americans since the year 1999. The crisis, though, looks much different today. Initially fueled by prescription painkillers, the epidemic was later shaped by heroin and, more recently, illicit fentanyl. Meanwhile, the epicenter of the crisis has moved from largely white, rural communities of the United States to communities of color. USC Price School Professor Rosalie Pacula joins the show to discuss this evolution of the opioid epidemic and her new research on the role that geography plays in shaping the crisis.

    Show More Show Less
    43 mins
  • The Pros and Cons of California’s Direct Democracy
    Sep 10 2025

    As Democrats and Republicans battle over redrawing congressional maps, California’s system of direct democracy is once again in the spotlight. For over a century, California has allowed citizens to directly pass or reject laws on high profile issues, from marijuana and gay marriage to homelessness and sports betting. But the state’s direct democracy system has come under scrutiny in recent years, with critics saying special interests have gained too much influence. To discuss the pros, cons and history of California’s direct democracy, we are joined by Mark Baldassare, senior fellow at the USC Price School’s Bedrosian Center on Governance.

    Show More Show Less
    27 mins
  • Saving Our Democracy
    Aug 6 2025

    The United States is one of history's most notable democracies, yet the U.S. democratic system has been in decline for years, with reduced public trust, increasing polarization and low levels of voter turnout. Our guest today, Mindy Romero, is among those spearheading “By the People, For the People,” a nationwide campaign that seeks to rebuild trust in U.S. democracy. She discusses the campaign and the challenges facing U.S. democracy.

    Show More Show Less
    24 mins
  • Closing the Revolving Door at HHS
    Jun 4 2025

    The Food and Drug Administration plans to ban employees of regulated companies, including drug manufacturers, from serving on the agency’s advisory committees. The new policy is aimed at combating industry influence and conflicts of interest, but will it make a difference? We are joined by Genevieve Kanter, an Associate Professor at the USC Price School, who has researched conflicts of interest at the FDA as well as the “revolving door” of people moving between jobs in government and regulated industries.

    Show More Show Less
    30 mins
  • The Economics of Disasters
    May 7 2025

    The Los Angeles wildfires were one of the costliest natural disasters in U.S. history, killing dozens of people and destroying thousands of homes and businesses. As catastrophes like this one become more common, we are joined by Research Professor Adam Rose, a leading expert in the economics of disasters. We discuss how these estimates are calculated and what can be done to make disasters less costly.

    Show More Show Less
    29 mins
  • A Solution to the Opioid Epidemic
    Apr 2 2025

    The opioid epidemic has killed roughly 900,000 Americans since the year 1999 – and one of the factors that fueled the crisis was doctors overprescribing opioids to patients. Jason Doctor, a USC Price School Professor, has been researching a way to curb overprescribing: notifying doctors when their patients fatally overdose. In this episode, we’ll discuss his studies and how they can help policymakers combat this health crisis.

    Show More Show Less
    28 mins
  • The Policy and Politics of DEI
    Mar 5 2025

    Diversity, Equity and Inclusion programs – commonly known as DEI – have become a hot-button issue in U.S. politics. Many organizations launched or expanded DEI programs in the wake of George Floyd’s murder by a police officer. Now, a backlash against DEI has turned into policymaking, with federal, state and local governments aiming to restrict or ban DEI programs. Shaun Harper, a University and Provost Professor at the USC Price School, joins the show to discuss policymakers’ actions against DEI and the potential consequences.

    Show More Show Less
    37 mins